Recombinant Danio rerio Phosphatidylserine Synthase 1 (ptdss1) is a laboratory-engineered form of the enzyme phosphatidylserine synthase 1 (PSS1) derived from zebrafish (Danio rerio). This enzyme catalyzes the calcium-dependent base-exchange reaction where L-serine replaces the polar head group of phosphatidylcholine (PC) or phosphatidylethanolamine (PE) to synthesize phosphatidylserine (PS), a phospholipid critical for membrane structure, apoptosis, and cell signaling . PS constitutes 5–10% of cellular membrane phospholipids and plays roles in blood coagulation and mineralisation .
PTDSS1 is a multi-pass transmembrane protein localized to the endoplasmic reticulum (ER). Recent studies using epitope tagging and immunofluorescence support a 10-transmembrane segment model (Figure 1), where:
Catalytic residues (e.g., eight critical amino acids) are positioned on the luminal side of the ER membrane.
Regulatory residues (e.g., nine amino acids) reside on the cytoplasmic side, enabling PS-mediated feedback inhibition .
The recombinant zebrafish PTDSS1 (UniProt ID: Q803C9) comprises 465 amino acids. Key domains include:
A conserved serine-exchange motif critical for substrate binding .
N-terminal His-tag for purification (e.g., in E. coli or HEK293 expression systems) .
| Property | Detail |
|---|---|
| Molecular Weight | ~55–60 kDa (including tags) |
| Expression System | E. coli, HEK293, mammalian cells |
| Tag Types | His, GST, Avi, or untagged |
Recombinant PTDSS1 is used to study PS biosynthesis kinetics. For example:
C14-serine incorporation assays measure PS/PE synthesis rates in transfected HEK293 cells .
Mutant variants (e.g., Leu137Phe) show loss-of-function, aiding studies on Lenz-Majewski syndrome (LMHD), a hyperostotic dwarfism disorder linked to PTDSS1 gain-of-function mutations .
LMHD-associated mutations (e.g., P269S) disrupt PS homeostasis, leading to dysregulated bone mineralization. Recombinant zebrafish PTDSS1 enables cross-species comparative studies of these mechanisms .
PTDSS1 participates in glycerophospholipid metabolism, interacting with enzymes like PTDSS2 and PLB1.
| Pathway | Associated Proteins |
|---|---|
| Glycerophospholipid metabolism | PTDSS2, PLB1, CDS2, DGKG |
| Metabolic pathways | HMGCR, CYP2C70, FBP1 |
Recombinant zebrafish PTDSS1 bridges structural biology and disease research:
This enzyme catalyzes a base-exchange reaction, substituting the polar head group of phosphatidylethanolamine (PE) or phosphatidylcholine (PC) with L-serine. While primarily catalyzing phosphatidylcholine conversion, it also converts phosphatidylethanolamine in vitro, albeit to a lesser extent.
Phosphatidylserine synthase 1 (PTDSS1), also known as PSS-1 or PtdSer synthase 1 (EC 2.7.8.29), is an enzyme responsible for catalyzing the synthesis of phosphatidylserine (PtdSer) in zebrafish. In Danio rerio, PTDSS1 functions as a serine-exchange enzyme that catalyzes the exchange of L-serine with the base moieties of phosphatidylcholine to form phosphatidylserine . This enzyme plays a critical role in the metabolism of amino-glycerophospholipids and membrane phospholipid composition, which is essential for normal cellular function and development in zebrafish.
PTDSS1 shows significant evolutionary conservation between zebrafish and mammals. Human and zebrafish PTDSS1 orthologues share 78% amino acid identity, indicating substantial functional conservation across vertebrate species . This high level of conservation suggests that the fundamental mechanisms of phosphatidylserine synthesis have been preserved throughout vertebrate evolution. The zebrafish PTDSS1 protein contains 465 amino acids with several conserved domains that are also present in mammalian counterparts . When comparing with Chinese hamster PSS1 and PSS2, these enzymes share approximately 32% amino acid identity with each other, with numerous conserved polar amino acid residues that are critical for enzymatic function .
Recombinant Danio rerio PTDSS1 can be produced using several expression systems, though the specific system may vary depending on experimental needs. The recombinant PTDSS1 protein available commercially is typically produced using bacterial or eukaryotic expression systems that have been optimized for protein folding and post-translational modifications. The expression region typically includes amino acids 1-465, representing the full-length protein . The recombinant protein is often supplied with a tag (determined during the production process) to facilitate purification and detection in experimental settings.
For optimal stability and activity of recombinant Danio rerio PTDSS1, the protein should be stored at -20°C in a Tris-based buffer containing 50% glycerol. For extended storage periods, it is recommended to store the protein at -20°C or -80°C . It is important to note that repeated freezing and thawing should be avoided as this can lead to protein denaturation and loss of enzymatic activity. For short-term use, working aliquots can be stored at 4°C for up to one week . Proper storage conditions are essential for maintaining the structural integrity and functional activity of the enzyme in experimental settings.
Based on systematic alanine mutagenesis studies of the related Chinese hamster PSS1, eight amino acid residues have been identified as crucial for serine base-exchange activity: His-172, Glu-197, Glu-200, Asn-209, Glu-212, Asp-216, Asp-221, and Asn-226 . Among these, Asn-209 appears to be particularly important for the recognition and/or binding of free L-serine . Given the high conservation between species, these residues likely play similar roles in Danio rerio PTDSS1.
The critical catalytic residues can be grouped based on their roles in the enzymatic mechanism:
| Amino Acid Residue | Proposed Function in Enzymatic Activity |
|---|---|
| His-172 | Potentially involved in proton transfer during catalysis |
| Glu-197, Glu-200 | May participate in substrate binding or catalytic mechanism |
| Asn-209 | Involved in recognition/binding of L-serine substrate |
| Glu-212, Asp-216, Asp-221 | Likely contribute to active site architecture |
| Asn-226 | May be involved in stabilizing the transition state |
These findings suggest that PTDSS1 employs a complex catalytic mechanism involving multiple amino acid residues that work in concert to facilitate the serine base-exchange reaction .
PTDSS1 activity is subject to feedback inhibition by its product, phosphatidylserine (PtdSer). This regulatory mechanism has been demonstrated in both intact cells and isolated membrane fractions . Six amino acid residues have been identified as critical for this feedback regulation in Chinese hamster PSS1: Arg-95, His-97, Cys-189, Arg-262, Gln-266, and Arg-336 .
When these residues are mutated to alanine, the resulting mutant enzymes show resistance to inhibition by exogenous PtdSer, suggesting that these residues participate in PtdSer-mediated inhibition of PTDSS1 . Interestingly, mutations affecting these regulatory residues result in enhanced PtdSer synthesis even in the absence of exogenous PtdSer, indicating that these residues are involved in both the basal regulation of enzyme activity and the response to exogenous PtdSer .
The regulatory mechanism appears to involve specific interactions between PtdSer and these key regulatory residues, which likely induce conformational changes in the enzyme that modulate its catalytic activity. For instance, when Arg-95 is mutated, binding of PtdSer to a putative regulatory site may cause activation instead of inhibition, possibly by stabilizing a different enzyme conformation .
Zebrafish models offer valuable platforms for studying the effects of PTDSS1 mutations associated with human disorders such as Lenz-Majewski syndrome (LMS). Several experimental approaches can be employed:
RNA Microinjection: Injecting physiologically high doses of RNA encoding human mutant forms of PTDSS1 into zebrafish embryos has been shown to cause developmental defects including axial abnormalities, eye loss, and jaw cartilage patterning defects . The frequency of these defects correlates with RNA dose, providing a biochemical readout of LMS gain-of-function mutation activity.
Transgenesis: Tol2 transposon-mediated transgenesis can be used to create stable transgenic zebrafish lines expressing wild-type or mutant forms of human PTDSS1 . This approach allows for tissue-specific expression using appropriate promoters, such as:
Ubiquitous expression
Chondrocyte-specific expression
Osteoblast-specific expression
Osteoclast-specific expression
CRISPR/Cas9 Gene Editing: Creating precise mutations in the endogenous zebrafish ptdss1 gene that mirror human disease mutations can provide more physiologically relevant models of LMS.
Measuring PTDSS1 enzymatic activity in zebrafish tissue samples requires specific biochemical assays that detect the serine base-exchange reaction. Several methodological approaches include:
Radioisotope Labeling: Incubating tissue homogenates or isolated membranes with radioactively labeled L-serine (e.g., [³H]serine or [¹⁴C]serine) and measuring the incorporation of the labeled serine into phosphatidylserine.
Mass Spectrometry: Using liquid chromatography-mass spectrometry (LC-MS) to quantify the formation of phosphatidylserine from phosphatidylcholine and free L-serine in tissue extracts.
Fluorescent Substrate Assays: Utilizing fluorescently labeled phospholipid substrates to monitor the base-exchange reaction in real-time.
Cell Homogenate Assays: Preparing homogenates from zebrafish tissues and measuring PtdSer synthesis in the presence and absence of exogenous PtdSer to assess both catalytic activity and feedback regulation .
When designing these assays, it is crucial to consider the optimal reaction conditions:
Buffer composition (typically Tris-based)
pH (usually in the physiological range)
Divalent cation requirements
Substrate concentrations
Temperature (typically 25-30°C for zebrafish enzyme assays)
Additionally, comparing wild-type PTDSS1 activity with that of mutant variants can provide insights into how specific amino acid residues contribute to catalytic function and regulation.
PTDSS1 plays a critical role in determining membrane phospholipid composition by catalyzing the production of phosphatidylserine (PtdSer), which in turn affects various cellular processes in developing zebrafish embryos. PtdSer is primarily located in the inner leaflet of plasma membranes and serves multiple functions:
Membrane Architecture: PtdSer contributes to membrane asymmetry and physical properties, which are essential for membrane protein function and cellular processes.
Cell Signaling: PtdSer externalization serves as an important signal for various cellular processes, including apoptosis and the clearance of dying cells during embryonic development.
Calcium-Dependent Protein Binding: Many signaling proteins contain domains that bind PtdSer in a calcium-dependent manner, affecting signal transduction pathways.
Research has shown that altered PTDSS1 function, particularly gain-of-function mutations, can lead to developmental abnormalities in zebrafish embryos, including axial defects, eye loss, and jaw cartilage patterning defects . These phenotypes suggest that dysregulated PtdSer synthesis disrupts normal developmental processes, possibly through altered cell signaling pathways or membrane protein function.
In addition, there appears to be a connection between PTDSS1 function and skeletal development, as transgenic zebrafish with altered PTDSS1 expression exhibited incompletely penetrant mild scoliosis of the vertebrae . This suggests that proper regulation of phospholipid metabolism is important for normal skeletal development and homeostasis.
When investigating structure-function relationships of Danio rerio PTDSS1, researchers should consider several important factors:
Mutagenesis Strategy: Systematic alanine scanning mutagenesis has proven effective for identifying critical residues in PSS1 . For Danio rerio PTDSS1, focusing on conserved polar amino acid residues that are shared with other species can be particularly informative.
Expression Systems: Choose appropriate expression systems that allow for proper protein folding and post-translational modifications. Mammalian cell lines (such as CHO-K1 cells) have been successfully used for expressing PSS1 mutants .
Membrane Protein Challenges: PTDSS1 is a membrane protein with multiple transmembrane domains, which can present challenges for expression, purification, and structural studies. Consider using detergents or nanodiscs for stabilizing the protein in solution.
Functional Assays: Develop robust assays to measure both enzymatic activity and regulatory properties. Base-exchange activity can be measured using radioactive or fluorescent substrates, while regulatory properties can be assessed by examining the response to exogenous PtdSer .
Protein Stability: Some mutations may affect protein stability rather than directly impacting catalytic or regulatory function. Western blot analysis can help distinguish between mutations that affect protein expression/stability versus those that affect function .
When faced with contradictory results in PTDSS1 research, consider these methodological approaches to reconcile discrepancies:
Experimental Conditions: Differences in buffer composition, pH, temperature, or substrate concentrations can significantly impact enzyme activity measurements. Standardizing these conditions across laboratories is essential for comparing results.
Species-Specific Differences: Despite high conservation, PTDSS1 from different species may exhibit subtle functional differences. When comparing results across species, consider the degree of sequence conservation in the specific regions under investigation.
Expression System Variations: The choice of expression system can affect protein folding, post-translational modifications, and membrane incorporation, potentially leading to functional differences in recombinant PTDSS1 proteins.
In vitro versus In vivo Studies: Results from in vitro enzymatic assays may not always align with observations in cellular or organismal models due to the complex regulatory environment in living systems.
Technical Replication: Ensuring robust technical replication and appropriate statistical analysis is critical for validating experimental findings and identifying potential sources of variability.
Complementary Approaches: Employing multiple experimental techniques (e.g., combining biochemical assays with structural studies and cellular models) can provide a more comprehensive understanding of PTDSS1 function and help resolve apparent contradictions.